tak 779 has been researched along with Acquired Immune Deficiency Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albert, J; Esbjörnsson, J; Fenyö, EM; Jansson, M; Karlsson, A; Medstrand, P; Öberg, M; Repits, J | 1 |
1 other study(ies) available for tak 779 and Acquired Immune Deficiency Syndrome
Article | Year |
---|---|
Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency.
Topics: Acquired Immunodeficiency Syndrome; Amides; CCR5 Receptor Antagonists; Chemokine CCL5; Enfuvirtide; HIV Envelope Protein gp41; HIV-1; Humans; Molecular Sequence Data; Peptide Fragments; Quaternary Ammonium Compounds; Virus Replication | 2005 |